Patents
Patents for C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
05/2006
05/30/2006US7053234 Antibacterial agents
05/25/2006US20060111553 Novel thrombin inhibitors, the preparation and use thereof
05/24/2006CN1775752A Optical pure diamide compound and its use
05/23/2006CA2158454C Taxanes having furyl or thienyl substituted side-chain
05/17/2006EP1656138A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity
05/17/2006CN1774418A Substituted N-arylheterocycles, method for production and use thereof as medicaments
05/17/2006CN1774245A Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof
05/16/2006US7045636 MCH antagonists for the treatment of obesity
05/16/2006US7045521 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents
05/16/2006US7045515 Anticholesterol agents
05/16/2006CA2237752C Novel substituted aryl compounds useful as modulators of acetylcholine receptors
05/11/2006WO2006049113A1 Intermediate for synthesizing carbapenem and method for preparation thereof
05/10/2006EP1654224A1 Substituted benzoylureido-o-benzoylamides, method for the production thereof and use of the same
05/10/2006EP1346981B1 Process for synthesizing beta-lactams
05/10/2006CN1255379C E-alpha-chloro alkyllene-beta-lactan compound synthetic method and its use
05/09/2006US7041836 Antibiotic compounds
05/03/2006EP1651597A2 N-sulphonylated amino acid derivatives, method for the production and use thereof
05/03/2006EP1444200B1 Azetidinyl diamines useful as ligands of the nociceptin receptor orl-1
05/03/2006CN1768034A Nover diphenylazetidinone with improved physiological properties, process for its preparation, medicaments comprising this compound, and its use
04/2006
04/27/2006WO2006019957A3 Heterocyclyls as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
04/27/2006US20060089357 Novel compounds and compositions as cathepsin inhibitors
04/25/2006US7034043 Cell adhesion inhibitors
04/20/2006WO2006040464A1 Method and intermediates for the preparation of derivatives of n-(1-benzhydryl-azetidin-3-yl)-n-phenyl-methylsulphonamide
04/20/2006WO2006040182A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
04/20/2006WO2006015194A3 Preparation of pyridonecarboxylic acid antibacterials
04/20/2006WO2006008612A3 Preparation of beta-amino acids having affinity for the alpha-2-delta protein
04/20/2006WO2005062897A3 Polymorphs of ezetimibe and processes for the preparation thereof
04/20/2006CA2583983A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
04/20/2006CA2581781A1 Method and intermediates for the preparation of derivatives of n-(1-benzhydryl-azetidin-3-yl)-n-phenyl-methylsulphonamide
04/18/2006US7030116 Compounds and compositions as cathepsin inhibitors
04/13/2006WO2005116027A3 Indazole and indolone derivatives and their use as pharmaceuticals
04/13/2006DE19637425B4 Neue N-Vinyllactam-Derivate und deren Polymere New N-vinyl lactam derivatives and their polymers
04/12/2006EP1343771B1 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors
04/11/2006US7026472 for example 1-(methylthio)-3-methoxy-4-(2-fluorophenyl)azetidin-2-one; induce neoplastic cell apoptosis or inhibit neoplastic cell proliferation
04/11/2006CA2322558C Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel
04/06/2006WO2005061452A8 Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity
04/06/2006WO2005061451A8 Diphenylazetidinone derivates processing cholesterol absorption inhibitory activity
04/05/2006EP0933993B1 Substituted cyclopentane compounds useful as neuraminidase inhibitors
04/05/2006CN1756752A Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
04/05/2006CN1249250C Stereoselective microbial reduction reaction for preparation of 1-(4-fluorophenyl)-3(R)-[3(s)-hydroxy-3-(4-fluorophenyl)propyl)-4(s)-(-4hydroxyphenyl)-2-azetidinone
04/04/2006US7022842 Process for synthesizing beta-lactam
04/04/2006US7022716 Cyclic amine phenyl beta-3 adrenergic receptor agonists
03/2006
03/30/2006WO2006034277A1 Bicyclic compounds which inhibit beta-secretase activity and methods of use thereof
03/30/2006US20060069137 Novel process for ezetimibe intermediate
03/30/2006CA2580238A1 Bicyclic compounds which inhibit beta-secretase activity and methods of use thereof
03/29/2006EP1638939A2 Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
03/29/2006EP1638551A2 Immunosuppressant compounds and compositions
03/29/2006CN1752086A Improved method of preparing azhediping
03/29/2006CN1247539C Preparation method of (S)-beta-azetidinone-4-benzyl carboxylate
03/28/2006US7019024 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
03/28/2006US7019000 administering nitrogen-sulfur compounds, e.g. 4,4-dithiodimorpholine to inhibit binding of the E6 protein by human papilloma virus; treatment of cervical cancer
03/28/2006US7018642 Compounds, compositions, and methods for controlling biofilms
03/23/2006WO2004101507A3 N-sulphonylated amino acid derivatives and use thereof as matriptase inhibitors
03/22/2006EP1636181A1 Substituted 3-alkyl and 3-alkenyl azetidine derivatives
03/21/2006US7015320 Process for the manufacture of optically active 3-substituted lactams by asymmetric hydrogenation of 3-alkylidenelactams
03/21/2006CA2263983C Cyclic amine derivatives for inhibiting blood platelet aggregation
03/21/2006CA2147854C Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them
03/16/2006US20060058521 when THF and water are distilled off while adding THF to maintain the reaction solution at a constant level, it is possible to avoid the reduction in isolated yield resulting from the decomposition of the beta -lactam compound
03/14/2006CA2312935C Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors
03/14/2006CA2289987C Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia
03/14/2006CA2147984C Butenyl-substituted taxanes and composition
03/14/2006CA2103838C Novel 7-(substituted)-8-(substituted-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
03/09/2006WO2005063239A9 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders
03/09/2006US20060052445 Diarylsulfones as 5-HT2A antagonists
03/09/2006US20060052314 Pharmaceutical combination
03/08/2006EP1631542A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
03/08/2006EP1339723B1 Process and ester derivatives useful for preparation of cephalosporins
03/02/2006WO2006021806A1 Arylsulphonylstilbene derivatives for treatment of insomnia and related conditions
03/02/2006WO2006021805A1 Diarylsulfones as 5-ht2a antagonists
03/02/2006CA2577837A1 Diarylsulfones as 5-ht2a antagonists
03/02/2006CA2575200A1 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
03/01/2006EP1628685A2 Antiviral phosphonate analogs
03/01/2006CN1243756C Process and ester derivatives for preparing cephalosporins
02/2006
02/23/2006US20060040985 Therapeutic agent for treating respiratory diseases containing 4-hydroxypiperidine derivative as active ingredient
02/22/2006EP1626954A2 Process for the preparation of trans-isomers of diphenylazetidinone derivatives
02/22/2006CN1242989C Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-ichibiting anti-inflammatory and immune-suppressive agents
02/21/2006US7002008 Process for the preparation of 1-(4-fluorophenyl)-4(S)-(4-hydroxyphenyl)-azetidin-2-one
02/16/2006WO2006015854A2 Azetidine derivatives as ccr-3 receptor antagonists
02/16/2006WO2005118544A3 Cycloalkyl substituted pyrimidinediamine compounds and their uses
02/16/2006US20060035891 (1S, 2R)-N4-(2-Aminocarbonylcyclopent-1-yl)-5-fluoro-N2-[4-(4-methylpiperazin-1-yl)-3-methylphenyl]-2,4-pyrimidinediamine, having antiproliferative activity, used to inhibit cellular proliferation and to treat proliferate diseases such as cancers
02/16/2006CA2572748A1 Organic compounds
02/08/2006EP1623974A1 2"-hydroxynicotianamine, process for producing the same and angiotensin converting enzyme inhibitor, hypotensive drug and health food
02/08/2006EP1622870A2 Glutaminyl based dp iv-inhibitors
02/08/2006EP1318978B1 N-acylsulfonamide apoptosis promoters
02/07/2006US6995183 Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods
02/07/2006CA2360308C Glucocorticoid receptor modulators
02/07/2006CA2200433C Phenyloxazolidinone antimicrobials
02/02/2006US20060025596 Method for deuteration or tritiation of heterocyclic ring
02/01/2006EP1620395A1 Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disorders
02/01/2006EP1620110A2 Immunomodulator phosphonate conjugates
02/01/2006EP1620102A2 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands
02/01/2006CN1727348A Derivant of cephalosporin alkene, and preparation method
02/01/2006CN1727334A Inhibitor of tricycro beta lactamase and preparation method
01/2006
01/31/2006US6992067 Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
01/26/2006WO2005077463A3 Ligand for a monoamine receptor or transporter for treating addiction or dependence
01/26/2006CA2573128A1 Preparation of beta-amino acids having affinity for the alpha-2-delta protein
01/25/2006EP1618105A1 Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disorders
01/25/2006EP1617848A2 Anti-cancer phosphonate conjugates
01/24/2006USRE38947 Method of enantioselectively catalyzing a reaction
01/19/2006WO2004113297A3 Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 69